Barely Significant
← all excerpts

Levosimendan improves exercise performance in patients with advanced chronic heart failure.

ESC Heart Fail · 2015 · PMC5042087 · PMID 27708855

Europe PMCDOI
1
hedged sentence
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

did not reach statistical significanceP = 0.09so close (0.05 < p ≤ 0.1)
A minor peak VO 2 increase was observed after the placebo treatment, although it did not reach statistical significance ( P = 0.09), while the patients treated with levosimendan showed a significant peak VO 2 improvement ( Figure 3 B ; Table 3 ; P = 0.005).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.